These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3617153)

  • 1. Evaluation of a Bayesian method of amikacin dosing in intensive care unit patients with normal or impaired renal function.
    Lacarelle B; Granthil C; Manelli JC; Bruder N; Francois G; Cano JP
    Ther Drug Monit; 1987 Jun; 9(2):154-60. PubMed ID: 3617153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of Bayesian estimation for the prediction of an appropriate dosage regimen of amikacin.
    Garraffo R; Iliadis A; Cano JP; Dellamonica P; Lapalus P
    J Pharm Sci; 1989 Sep; 78(9):753-7. PubMed ID: 2585270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive performance of two software packages (USC*PACK PC and Abbott PKS system) for the individualization of amikacin dosage in intensive care unit patients.
    Gauthier T; Lacarelle B; Marre F; Villard PH; Catalin J; Durand A
    Int J Biomed Comput; 1994 Jun; 36(1-2):131-4. PubMed ID: 7927852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abbott PKS system: a new version for applied pharmacokinetics including Bayesian estimation.
    Lacarelle B; Pisano P; Gauthier T; Villard PH; Guder F; Catalin J; Durand A
    Int J Biomed Comput; 1994 Jun; 36(1-2):127-30. PubMed ID: 7927851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.
    Mar Fernández de Gatta MD; Victoria Calvo M; Ardanuy R; Domínguez-Gil A; Lanao JM; Moreno SR
    J Pharm Pharmacol; 2009 Jun; 61(6):759-66. PubMed ID: 19505366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and dosage regimens of amikacin in intensive care unit patients.
    Debord J; Voultoury JC; Lachatre G; Favereau JP; Gay R
    Int J Biomed Comput; 1994 Jun; 36(1-2):135-7. PubMed ID: 7927853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population pharmacokinetic parameters for Bayesian monitoring of amikacin therapy in intensive care unit patients.
    Debord J; Voultoury JC; Lachatre G; Gay C; Favereau JP; Gay R
    Eur J Clin Pharmacol; 1992; 43(4):435-6. PubMed ID: 1451727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Population pharmacokinetics of amikacin in intensive care unit patients studied by NPEM algorithm.
    Debord J; Pessis C; Voultoury JC; Marquet P; Lotfi H; Merle L; Lachâtre G
    Fundam Clin Pharmacol; 1995; 9(1):57-61. PubMed ID: 7768489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population pharmacokinetic analysis of amikacin and validation on neonates using Monte Carlo method.
    Wang J; Liang WQ; Wu JJ; Pan CM
    Acta Pharmacol Sin; 2000 Oct; 21(10):954-60. PubMed ID: 11501052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of once-daily amikacin in pediatric patients.
    Belfayol L; Talon P; Eveillard M; Alet P; Fauvelle F
    Clin Microbiol Infect; 1996 Feb; 2(3):186-191. PubMed ID: 11866842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
    Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
    J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Population pharmacokinetics of amikacin in critically ill patients.
    Bressolle F; Gouby A; Martinez JM; Joubert P; Saissi G; Guillaud R; Gomeni R
    Antimicrob Agents Chemother; 1996 Jul; 40(7):1682-9. PubMed ID: 8807062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of amikacin use and comparison of the models implemented in two Bayesian forecasting software packages to guide dosing.
    Ryan AC; Carland JE; McLeay RC; Lau C; Marriott DJE; Day RO; Stocker SL
    Br J Clin Pharmacol; 2021 Mar; 87(3):1422-1431. PubMed ID: 32881037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic variability of nimodipine disposition after single and multiple oral dosing to hypertensive renal failure patients: parametric and nonparametric population analysis.
    Terziivanov D; Atanasova I; Dimitrova V; Robeva R; Unger S; Mück W
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):404-12. PubMed ID: 10475143
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian feedback method of aminoglycoside dosing.
    Burton ME; Brater DC; Chen PS; Day RB; Huber PJ; Vasko MR
    Clin Pharmacol Ther; 1985 Mar; 37(3):349-57. PubMed ID: 3971658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical application of amikacin dosage based upon lean body mass in patients with different renal function.
    Wagenvoort JH; Fieren MW; Goessens WH; Michel MF
    Chemotherapy; 1984; 30(2):69-75. PubMed ID: 6697814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amikacin Bayesian forecasting in critically ill patients with sepsis and cirrhosis.
    Lugo G; Castañeda-Hernández G
    Ther Drug Monit; 1997 Jun; 19(3):271-6. PubMed ID: 9200766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-a-day individualized amikacin dosing for suspected infection at birth based on population pharmacokinetic models.
    Labaune JM; Bleyzac N; Maire P; Jelliffe RW; Boutroy MJ; Aulagner G; Putet G
    Biol Neonate; 2001 Aug; 80(2):142-7. PubMed ID: 11509814
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
    Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
    Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing Amikacin Dosage in Pediatrics Based on Population Pharmacokinetic/Pharmacodynamic Modeling.
    Alqahtani S; Abouelkheir M; Alsultan A; Elsharawy Y; Alkoraishi A; Osman R; Mansy W
    Paediatr Drugs; 2018 Jun; 20(3):265-272. PubMed ID: 29569124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.